Cwm LLC Has $1.61 Million Stock Position in GRAIL, Inc. $GRAL

Cwm LLC grew its holdings in shares of GRAIL, Inc. (NASDAQ:GRAL) by 37.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,239 shares of the company’s stock after buying an additional 8,524 shares during the quarter. Cwm LLC’s holdings in GRAIL were worth $1,606,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in GRAL. Wealthquest Corp acquired a new position in shares of GRAIL during the first quarter valued at about $18,247,000. AQR Capital Management LLC grew its holdings in shares of GRAIL by 61.0% during the first quarter. AQR Capital Management LLC now owns 1,337,163 shares of the company’s stock valued at $33,991,000 after buying an additional 506,440 shares during the last quarter. Raymond James Financial Inc. grew its holdings in shares of GRAIL by 354.7% during the first quarter. Raymond James Financial Inc. now owns 121,169 shares of the company’s stock valued at $3,095,000 after buying an additional 94,518 shares during the last quarter. Aberdeen Group plc grew its holdings in shares of GRAIL by 34.9% during the first quarter. Aberdeen Group plc now owns 284,735 shares of the company’s stock valued at $7,272,000 after buying an additional 73,667 shares during the last quarter. Finally, Informed Momentum Co LLC acquired a new position in shares of GRAIL during the first quarter valued at about $1,881,000.

Wall Street Analysts Forecast Growth

GRAL has been the topic of several analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of GRAIL in a report on Wednesday, October 8th. Canaccord Genuity Group boosted their price target on shares of GRAIL from $43.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, October 3rd. Finally, UBS Group set a $75.00 price target on shares of GRAIL in a report on Friday, October 3rd. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, GRAIL has a consensus rating of “Hold” and an average price target of $56.67.

GRAIL Stock Performance

GRAIL stock opened at $78.00 on Monday. GRAIL, Inc. has a fifty-two week low of $12.76 and a fifty-two week high of $89.57. The stock has a market cap of $2.81 billion, a PE ratio of -5.95 and a beta of 4.11. The firm’s 50-day simple moving average is $46.19 and its 200 day simple moving average is $40.29.

GRAIL (NASDAQ:GRAL) last announced its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) EPS for the quarter, missing the consensus estimate of ($3.14) by ($0.04). The company had revenue of $35.54 million during the quarter, compared to the consensus estimate of $37.57 million. GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%. As a group, analysts predict that GRAIL, Inc. will post -15.15 EPS for the current fiscal year.

Insider Activity

In other GRAIL news, President Joshua J. Ofman sold 6,114 shares of GRAIL stock in a transaction dated Thursday, October 16th. The shares were sold at an average price of $82.01, for a total value of $501,409.14. Following the sale, the president owned 381,818 shares of the company’s stock, valued at approximately $31,312,894.18. The trade was a 1.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Robert P. Ragusa sold 7,239 shares of GRAIL stock in a transaction dated Wednesday, October 15th. The stock was sold at an average price of $68.88, for a total transaction of $498,622.32. Following the completion of the sale, the chief executive officer directly owned 727,388 shares in the company, valued at approximately $50,102,485.44. This represents a 0.99% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 117,497 shares of company stock worth $7,515,436.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.